NCT00005646View on ClinicalTrials.gov

Paclitaxel in Treating Patients With Extensive-Stage Small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

April 30, 2000

Primary Completion Date

January 31, 2004

Study Completion Date

February 29, 2008

Conditions
Lung Cancer
Interventions
DRUG

paclitaxel

150 mg/sq m IV over 3 hours weekly for 6 weeks per cycle

Trial Locations (5)

13210

State University of New York - Upstate Medical University, Syracuse

27710

Duke Comprehensive Cancer Center, Durham

65203

Ellis Fischel Cancer Center - Columbia, Columbia

27599-7295

Lineberger Comprehensive Cancer Center, UNC, Chapel Hill

29425-0721

Medical University of South Carolina, Charleston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Alliance for Clinical Trials in Oncology

OTHER

NCT00005646 - Paclitaxel in Treating Patients With Extensive-Stage Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter